PRICE T ROWE ASSOCIATES INC /MD/ - APTEVO THERAPEUTICS INC ownership

APTEVO THERAPEUTICS INC's ticker is APVO and the CUSIP is 03835L207. A total of 24 filers reported holding APTEVO THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of APTEVO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$16
-76.5%
46,2000.0%0.00%
Q2 2023$68
-28.4%
46,2000.0%0.00%
Q1 2023$95
-11.2%
46,2000.0%0.00%
Q4 2022$107
-99.9%
46,2000.0%0.00%
Q3 2022$141,000
-14.5%
46,2000.0%0.00%
Q2 2022$165,000
-39.1%
46,2000.0%0.00%
Q1 2022$271,000
-25.5%
46,2000.0%0.00%
Q4 2021$364,000
+57.6%
46,200
+633.3%
0.00%
Q4 2020$231,0006,3000.00%
Other shareholders
APTEVO THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
CANTOR FITZGERALD, L. P. 215,200$4990.01%
Schonfeld Strategic Advisors LLC 142,100$329,6720.00%
TWO SIGMA SECURITIES, LLC 14,877$34,5150.00%
FIFTH THIRD BANCORP 291$6750.00%
FRANKLIN RESOURCES INC 10,997$25,5130.00%
BANK OF AMERICA CORP /DE/ 11$260.00%
PNC FINANCIAL SERVICES GROUP, INC. 142$3290.00%
MONEY CONCEPTS CAPITAL CORP 7$160.00%
WELLS FARGO & COMPANY/MN 1,613$3,7420.00%
NORTHERN TRUST CORP 17,338$40,2240.00%
View complete list of APTEVO THERAPEUTICS INC shareholders